Evidence map›Paper›PMID 38421578›Full record

ReviewCNS drugs2024

Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis.

Anastasiia D Shkodina, Mainak Bardhan, Hitesh Chopra, Onyekachi Emmanuel Anyagwa, Viktoriia A Pinchuk, Kateryna V Hryn, Anzhelina M Kryvchun, Dmytro I Boiko, Vinay Suresh, Amogh Verma and 1 more

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in CNS drugs, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07741864 (Effectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis), which is not on this map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07741864 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Effectiveness of a Mindfulness-Based Intervention for Pain Management in Patients With Multiple Sclerosis

TypeinterventionalSponsorHospital Universitario Virgen MacarenaRan2026 to 2027Enrolled84ConditionsMultiple Sclerosis, Pain, Pain ManagementArmsMindfulness-based intervention, Educational intervention
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Targeting NaInternational journal of molecular sciences · 2026
    Review
  5. Review
  6. Article
  7. Review
  8. Multiple sclerosis: molecular pathogenesis and therapeutic intervention.Signal transduction and targeted therapy · 2025
    Review
  9. Article
  10. MEDICATION EXPOSURE AND NEURODEGENERATIVE DISEASE RISK ACROSS NATIONAL BIOBANKS.medRxiv : the preprint server for health sciences · 2025
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Anastasiia D ShkodinaDepartment of Neurological diseases, Poltava State Medical University, Poltava, Ukraine.ORCID http://orcid.org/0000-0002-7198-5498
Mainak BardhanNeuro Medical Oncology, Miami Cancer Institute, Baptist Health South Florida, 8900 N. Kendall Drive, Miami, FL, 33176, USA. bardhan.mainak@gmail.com.ORCID http://orcid.org/0000-0002-4106-409X
Hitesh ChopraDepartment of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Chennai, 602105, Tamil Nadu, India.ORCID http://orcid.org/0000-0001-8867-7603
Onyekachi Emmanuel AnyagwaNew Vision University, Tbilisi, Georgia.ORCID http://orcid.org/0000-0002-2991-9833
Viktoriia A PinchukDepartment of Neurological diseases, Poltava State Medical University, Poltava, Ukraine.ORCID http://orcid.org/0000-0003-0622-0322
Kateryna V HrynDepartment of Neurological diseases, Poltava State Medical University, Poltava, Ukraine.ORCID http://orcid.org/0000-0002-8759-3560
Anzhelina M KryvchunDepartment of Neurological diseases, Poltava State Medical University, Poltava, Ukraine.ORCID http://orcid.org/0000-0003-0987-6503
Dmytro I BoikoDepartment of Psychiatry, Narcology and Medical Psychology, Poltava State Medical University, Poltava, Ukraine.ORCID http://orcid.org/0000-0001-7336-0822
Vinay SureshKing George's Medical University, Lucknow, India.ORCID http://orcid.org/0000-0002-1401-9154
Amogh VermaRama Medical College Hospital and Research Centre, Hapur, India.ORCID https://orcid.org/0000-0003-2499-4874
Mykhailo Yu DelvaDepartment of Neurological diseases, Poltava State Medical University, Poltava, Ukraine.ORCID https://orcid.org/0000-0001-5648-7506
Poltava V.G. Korolenko National Pedagogical University · UABaptist Hospital of Miami · USKing George's Medical University · INPoltava State Medical University · UARama Hospital & Research Centre · INSaveetha University · IN

Funding

Poltava State Medical University 0120U104165Poltava State Medical University 0121U108235
6 · The paper itself

Abstract

Multiple sclerosis is a chronic inflammatory disease that affects the central nervous system and can cause various types of pain including ongoing extremity pain, Lhermitte's phenomenon, trigeminal neuralgia, and mixed pain. Neuropathic pain is a major concern for individuals with multiple sclerosis as it is directly linked to myelin damage in the central nervous system and the management of neuropathic pain in multiple sclerosis is challenging as the options available have limited efficacy and can cause unpleasant side effects. The literature search was conducted across two databases, PubMed, and Google Scholar. Eligible studies included clinical trials, observational studies, meta-analyses, systematic reviews, and narrative reviews. The objective of this article is to provide an overview of literature on pharmacological and non-pharmacological strategies employed in the management of neuropathic pain in multiple sclerosis. Pharmacological options include cannabinoids, muscle relaxants (tizanidine, baclofen, dantrolene), anticonvulsants (benzodiazepines, gabapentin, phenytoin, carbamazepine, lamotrigine), antidepressants (duloxetine, venlafaxine, tricyclic antidepressants), opioids (naltrexone), and botulinum toxin variants, which have evidence from various clinical trials. Non-pharmacological approaches for trigeminal neuralgia may include neurosurgical methods. Non-invasive methods, physical therapy, and psychotherapy (cognitive behavioral therapy, acceptance and commitment therapy and mindfulness-based stress reduction) may be recommended for patients with neuropathic pain in multiple sclerosis. The choice of treatment depends on the severity and type of pain as well as other factors, such as patient preferences and comorbidities. There is a pressing need for healthcare professionals and researchers to prioritize the development of better strategies for managing multiple sclerosis-induced neuropathic pain.

Indexed as

Acceptance and Commitment TherapyMultiple SclerosisNeuralgiaTrigeminal NeuralgiaAnticonvulsantsAntidepressive AgentsHumansAnticonvulsantsAntidepressive Agents

Identifiers

PMID38421578
OpenAlexW4392293990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.